|
Market Closed -
Nasdaq
04:00:00 2026-09-04 pm EDT
|
5-day change | 1st Jan Change | ||
| 23.53 USD | -0.72% |
|
-7.18% | -49.18% |
| Aug. 13 | Collegium Pharmaceutical Enters $50 Million Accelerated Share Repurchase Agreement | MT |
| Aug. 06 | Collegium Pharmaceutical, Inc. Revises Earnings Guidance for the Year 2026 | CI |
Turnover - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
EBIT
- Stock Market
- Stocks
- COLL Stock
- Consensus Collegium Pharmaceutical, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
